ijms-logo

Journal Browser

Journal Browser

Neurogenesis and Neurodegeneration: Insights into Regeneration and the Impact of Neurotrophins

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 268

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, Naples, Italy
Interests: adult neurogenesis; aging; neurodegeneration; teleost animal models marine vertebrates; neurotrophins; immunohistochemistri; in situ hybridization
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Our Special Issue, "Neurogenesis and Neurodegeneration: Insights into Regeneration and the Impact of Neurotrophins", aims to showcase cutting-edge research that illuminates the complex relationship between the birth of new neurons and the progressive loss of existing ones—processes that are fundamentally linked to brain health, disease, and therapeutic intervention. 

We encourage scientists worldwide to submit original research articles, comprehensive reviews, and insightful perspectives that explore the intricate mechanisms that drive neurogenesis, with a particular focus on the critical role of neurotrophins. We welcome studies that explore regenerative strategies for neurodegenerative disorders, including those that consider the impact of environmental factors and genetic predisposition on both neurogenesis and neurodegeneration.

Leading by Dr. Eva Terzibasi Tozzini and assisting by Dr. Sara Bagnoli (Biology Laboratory (BIO@SNS), Scuola Normale Superiore, Italy), this Special Issue aims to provide a comprehensive platform for advances in the understanding of brain plasticity, repair mechanisms, and promising therapeutic avenues. 

Submit your work and help shape the future of neurogenesis, neurodegeneration, and regeneration research! We look forward to receiving your submission.

Dr. Eva Terzibasi Tozzini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurogenesis
  • neurodegeneration and regeneration
  • neurotrophins
  • brain plasticity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 1404 KiB  
Review
Hippocampal Neurogenesis in Alzheimer’s Disease: Multimodal Therapeutics and the Neurogenic Impairment Index Framework
by Li Ma, Qian Wei, Ming Jiang, Yanyan Wu, Xia Liu, Qinghu Yang, Zhantao Bai and Liang Yang
Int. J. Mol. Sci. 2025, 26(13), 6105; https://doi.org/10.3390/ijms26136105 - 25 Jun 2025
Viewed by 146
Abstract
Alzheimer’s disease (AD) is characterized by progressive cognitive decline strongly associated with impaired adult hippocampal neurogenesis (AHN). Mounting evidence suggests that this impairment results from both the intrinsic dysfunction of neural stem cells (NSCs)—such as transcriptional alterations in quiescent states—and extrinsic niche disruptions, [...] Read more.
Alzheimer’s disease (AD) is characterized by progressive cognitive decline strongly associated with impaired adult hippocampal neurogenesis (AHN). Mounting evidence suggests that this impairment results from both the intrinsic dysfunction of neural stem cells (NSCs)—such as transcriptional alterations in quiescent states—and extrinsic niche disruptions, including the dysregulation of the Reelin signaling pathway and heightened neuroinflammation. Notably, AHN deficits may precede classical amyloid-β and Tau pathology, supporting their potential as early biomarkers of disease progression. In this review, we synthesize recent advances in therapeutic strategies aimed at restoring AHN, encompassing pharmacological agents, natural products, and non-pharmacological interventions such as environmental enrichment and dietary modulation. Emerging approaches—including BDNF-targeted nanocarriers, NSC-derived extracellular vesicles, and multimodal lifestyle interventions—highlight the translational promise of enhancing neurogenesis in models of familial AD. We further propose the Neurogenesis Impairment Index (NII)—a novel composite metric that quantifies hippocampal neurogenic capacity relative to amyloid burden, while adjusting for demographic and cognitive variables. By integrating neurogenic potential, cognitive performance, and pathological load, NII provides a framework for stratifying disease severity and guiding personalized therapeutic approaches. Despite ongoing challenges—such as interspecies differences in neurogenesis rates and the limitations of stem cell-based therapies—this integrative perspective offers a promising avenue to bridge mechanistic insights with clinical innovation in the development of next-generation AD treatments. Full article
Show Figures

Figure 1

Back to TopTop